CClinicalTrials.gg
CompletedNCT04358822Updated Apr 24, 2020

Hemodynamic Effects of Delayed Umbilical Cord Clamping in Full-term Newborns

An interventional study of Delayed cord clamping in Cardiac Output, High and Cardiac Output, Low, sponsored by Cairo University. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2020-04-24.

Sponsored by Cairo University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Sex
All
01

Study summary

The sequence of events at the time of delivery includes delivery of the infant, clamping of the umbilical cord, and lastly delivery of the placenta. There are some benefits for delayed cord clamping. This study aims to compare the effects of two different duration of delayed cord clamping.

Infants will be randomized into two groups based on the duration of delayed cord clamping: 30 seconds vs 120 seconds. Different hemodynamic effects will be measured in each group at different time intervals. The hypothesis of the study is that delayed cord clamping for 120 seconds is associated with better cardiac output and with other hemodynamic advantages.

Read the detailed description

The study will include full term infants delivered via cesarean section. Written informed consent for participation in the study will be obtained from parents prior to delivery. Newborns will be randomly assigned into two groups according to the duration of cord clamping: Group 1: the cord will be clamped at 30 seconds, and Group 2: the cord will be clamped at 120 seconds of life. Stopwatch will be started when infants buttocks (or head if breech) are delivered from the uterus. The time elapsed will be counted aloud by the investigator in 10-second intervals. During this time, the infant will be held in linen on the mothers legs. Care will be taken not to apply traction on the cord. Milking of the cord will not be allowed. Immediately after resuscitation, infants will be attached to the leads of the electrical cardiometry device. Device output will be imported at 5, 10, and 15 minutes after birth in both groups. A follow up measurement will be imported later at 24 hours of age. In addition, a peripheral blood sample will be obtained at 24 hours of age for assessment of hemoglobin, glucose and bilirubin concentrations. .

The calculated sample size is 31 newborns in each group. This number will be adequate to detect an effect size of 10% in the mean cardiac output between the two groups with 95% confidence and 80% power. The study plans to recruit 34 infants in each group (10% attrition rate).

02

Conditions studied

  • Cardiac Output, High
  • Cardiac Output, Low
03

In context

Cardiac Output, Low

94 studies on the registry are indexed under Cardiac Output, Low; 15 are open to participants now.

This study's enrollment of 68 is close to the median of 65 across 46 interventional studies indexed under Cardiac Output, Low.

Browse Cardiac Output, Low studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Normal full term newborns ≥37 weeks gestational age
  • Both genders are included
  • Singleton
  • Delivered by elective cesarean section due to previous cesarean section, cephalo-pelvic disproportion, or mal-presentation
  • Successfully transitioned without need for respiratory or medication support

Exclusion criteria

Exclusion Criteria:

  • Neonates needing any active resuscitation
  • In-utero fetal distress
  • Suspected perinatal asphyxia
  • Major congenital malformations
  • Twin or multiple gestation
  • Intrauterine growth restriction
  • Placenta previa
  • Mothers with cardiac disorders
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
68 participants (actual)

Study arms

  • Active comparator
    30 second cord clamping

    Infants in this group will receive delayed cord clamping for 30 seconds.

    Procedure: Delayed cord clamping

  • Active comparator
    120 second cord clamping

    Infants in this group will receive delayed cord clamping for 120 seconds.

    Procedure: Delayed cord clamping

Interventions

  • ProcedureDelayed cord clamping

    The umbilical cord will be clamped after specific time intervals

06

What researchers measure

Primary outcomes

  1. Cardiac output

    Data imported from the electrical cardiometry device

    Time frame: at 15 minutes

  2. Stroke volume

    Data imported from the electrical cardiometry device

    Time frame: at 15 minutes

  3. Cardiac index

    Data imported from the electrical cardiometry device

    Time frame: at 15 minutes

  4. Index of contractility

    Data imported from the electrical cardiometry device

    Time frame: at 15 minutes

  5. Heart rate

    Data imported from the electrical cardiometry device

    Time frame: at 15 minutes

  6. Oxygen saturation

    Data imported from the electrical cardiometry device

    Time frame: at 15 minutes

Secondary outcomes

  1. Hemoglobin concentration

    Blood sample will be obtained an analyzed

    Time frame: At 24 hours

  2. Serum glucose concentration

    Blood sample will be obtained an analyzed

    Time frame: At 24 hours

  3. Serum bilirubin concentration

    Blood sample will be obtained an analyzed

    Time frame: At 24 hours

07

Study locations

1 site
  • Cairo University Children's Hospital
    Cairo, Egypt
08

References and documents

Publications

  • Katheria AC, Wozniak M, Harari D, Arnell K, Petruzzelli D, Finer NN. Measuring cardiac changes using electrical impedance during delayed cord clamping: a feasibility trial. Matern Health Neonatol Perinatol. 2015 May 22;1:15. doi: 10.1186/s40748-015-0016-3. eCollection 2015. PubMed 27057332 ↗
  • Chopra A, Thakur A, Garg P, Kler N, Gujral K. Early versus delayed cord clamping in small for gestational age infants and iron stores at 3 months of age - a randomized controlled trial. BMC Pediatr. 2018 Jul 18;18(1):234. doi: 10.1186/s12887-018-1214-8. PubMed 30021580 ↗
  • Hsu KH, Wu TW, Wang YC, Lim WH, Lee CC, Lien R. Hemodynamic reference for neonates of different age and weight: a pilot study with electrical cardiometry. J Perinatol. 2016 Jun;36(6):481-5. doi: 10.1038/jp.2016.2. Epub 2016 Feb 18. PubMed 26890553 ↗
  • Mercer JS, Erickson-Owens DA, Collins J, Barcelos MO, Parker AB, Padbury JF. Effects of delayed cord clamping on residual placental blood volume, hemoglobin and bilirubin levels in term infants: a randomized controlled trial. J Perinatol. 2017 Mar;37(3):260-264. doi: 10.1038/jp.2016.222. Epub 2016 Dec 8. PubMed 27929530 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 24, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04358822
Lead sponsor
Cairo University
Responsible party
Dr. Reem Mahmoud (Associate Professor of Pediatrics, Cairo University) — Principal investigator
First posted
Apr 24, 2020
Start date
Jan 21, 2020
Primary completion
Mar 31, 2020
Completion
Mar 31, 2020
Last update
Apr 24, 2020

Study contacts

Reem Mahmoud
principal investigator · Cairo University Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion